Patents Assigned to Catylix, Inc.
  • SELECTIVE ANDROGEN RECEPTOR MODULATORS
    Publication number: 20150057452
    Abstract: Compounds having therapeutic potential as androgen receptor modulators, and methods of making such compounds, are provided. The compounds are structurally related to bicalutamide but bear at least one difluoromethyl or C2 to C5 perfluoroalkyl group instead of a trifluoromethyl group.
    Type: Application
    Filed: April 4, 2013
    Publication date: February 26, 2015
    Applicant: Catylix, Inc.
    Inventors: James David Rozzell, Raymond McCague